Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Oral PresentationsOpen Access

05 A novel approach for neoantigen discovery from splicing factor mutated cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

TMTimothy J. MitchellTYT. YaoSMSayan Mukherjee

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mitchell et al. (2024) studied this question.

synapsesocial.com/papers/68e76604b6db6435876db978https://doi.org/10.1136/jitc-2024-itoc10.12
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SpliceUp: Predicting <i>SF3B1</i> mutations in individual cells via aberrant splice site activation from scRNA-seq data2025 · 2 citations
  2. 2Novel therapeutics for SF3B1 mutant cancers which exploit the missplicing of DCAF162025 · 1 citations
  3. 3TCR-T cells targeting a public neoantigen produced by the SF3B1 K700E mutation kill SF3B1-mutant AML/MDS2025
  4. 4Abstract 5952: A unifying mechanism for shared splicing aberrations in splicing factor mutant cancers2026
  5. 5SF3B1 mutations K700E, K666N, and R625H: Gene expression and aberrant splicing consequences2025